By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Electrical bioimpedance is a potent noninvasive method for identifying tissue and tracking the changes in its properties over time.
To put it another way, it involves measuring the electrical characteristics of tissues as a function of frequency. Therefore, it is a spectroscopic approach.
By passing a tiny alternating current through the body and measuring the impedance, bioelectrical impedance analysis (BIA) is used to determine how dense the human body is.
Because of the contact resistance between the electrode and human skin, BIA devices have smaller electrodes, which increases the impedance measurement inaccuracy.
The Global Bioimpedance sensor market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
Sales in this market are probably going to be driven by the rising number of weight loss clinics, fitness clubs, and sports rehabilitation facilities around the world.
In the near future, the demand for bioelectrical impedance devices is also expected to increase due to the general public’s growing knowledge of the advantages of living a healthy lifestyle.
Sales are expected to increase due to bioimpedance machines’ capacity to forecast muscle mass and improve patient glomerular activity rates.
In addition to this, it is projected that continued technological developments in the area of glomerular filtration rate detection will lead to the creation of small, lightweight, and user-friendly devices, which will increase demand for them.
Technology improvements and numerous product introductions have an impact on the global market for bioimpedance devices.
Market expansion is affected by macroeconomic, governmental, and industry factors. An important driver of market growth, some of the major competitors are introducing cutting-edge products that can test muscle mass, muscle quality, visceral fat, and body fat percentage.
In addition, the industry is predicted to be supported by the global healthcare sector’s fast digitization. Presently, a large number of influential firms are working to provide affordable yet clinically useful products to address the significant unmet medical requirements of patients.
Additionally, the market is expected to grow as a result of regulatory organisations’ growing investments in the improvement of the healthcare infrastructure.